Inventor · disambiguated record
Thierry Hercend
Also filed as: HERCEND THIERRY
19 granted patents·1 pending application·528 citations·filing 1984–2007
96Inventor score
Files withROUSSEL UCLAF4HOECHST MARION ROUSSEL INC3INST NAT SANTE RECH MED3ROUSSY INST GUSTAVE3AVENTIS PHARMA SA2
Top patents by PatentIndex Score
20 records- 0193US5773578AProteins produced by human lymphocytes, DNA sequence encoding these proteins and their pharmaceutical and biological useINST NAT SANTE RECH MED·Filed 1995·Granted Jun 30, 1998·103 cites·2 claims
- 0289US6143273ATherapeutic composition containing antibodies to soluble polypeptide fractions of LAG-3 proteinROUSSY INST GUSTAVE·Filed 1998·Granted Nov 7, 2000·80 cites·5 claims
- 0387US5976877AProteins produced by human lymphocytes DNA sequence encoding these proteins and their pharmaceutical and biological usesINST NAT SANTE RECH MED·Filed 1995·Granted Nov 2, 1999·69 cites·6 claims
- 0485US7294712B2Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesAVENTIS PHARMA SA·Filed 2002·Granted Nov 13, 2007·13 cites·5 claims
- 0585US5874250ADNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3INST NAT SANTE RECH MED·Filed 1995·Granted Feb 23, 1999·52 cites·10 claims
- 0684US7807659B2Caspase inhibitors and uses thereofVERTEX PHARMA·Filed 2006·Granted Oct 5, 2010·9 cites·12 claims
- 0782US5955300ASoluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodiesROUSSY INST GUSTAVE·Filed 1995·Granted Sep 21, 1999·35 cites·10 claims
- 0881USRE38313ESoluble polypeptide fractions of the LAG-3 protein, production method, therapeutic composition, anti-idiotype antibodiesROUSSY INST GUSTAVE·Filed 1995·Granted Nov 11, 2003·49 cites·15 claims
- 0977US5700907ANucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesROUSSEL UCLAF·Filed 1995·Granted Dec 23, 1997·24 cites·6 claims
- 1070US7960398B2Regulation of TNF-alphaVERTEX PHARMA·Filed 2003·Granted Jun 14, 2011·5 cites·1 claims
- 1166US8709426B2Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesHERCEND THIERRY·Filed 2007·Granted Apr 29, 2014·0 cites·11 claims
- 1265US6114516ANucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic musesHOECHST MARION ROUSSEL INC·Filed 1998·Granted Sep 5, 2000·16 cites·4 claims
- 1364US5798231ANucleotide sequences for α chain variable regions in human lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesROUSSEL UCLAF·Filed 1996·Granted Aug 25, 1998·15 cites·9 claims
- 1463US5817511ANucleotide sequence coding for variable regions of the α chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesROUSSEL UCLAF·Filed 1995·Granted Oct 6, 1998·15 cites·6 claims
- 1561US4772552AMonoclonal antibody which recognizes a 200-220 KD antigen on natural killer cellsDANA FARBER CANCER INST INC·Filed 1984·Granted Sep 20, 1988·8 cites·14 claims
- 1660US5830758AIsolated Vβ TCR antibodiesROUSSEL UCLAF·Filed 1995·Granted Nov 3, 1998·13 cites·2 claims
- 1755US6596536B1Nucleotide sequences coding for variable regions of the alpha chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic usesAVENTIS PHARMA SA·Filed 1995·Granted Jul 22, 2003·20 cites·6 claims
- 1844US2003096737A1Caspase inhibitors and uses thereofFiled 2002·Application pending·0 cites
- 1932US6020477ADNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzymeHOECHST MARION ROUSSEL INC·Filed 1995·Granted Feb 1, 2000·2 cites·2 claims
- 2026US6180386B1DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzymeHOECHST MARION ROUSSEL INC·Filed 1999·Granted Jan 30, 2001·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Thierry Hercend files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →